Interparfums (IPAR) Competitors $106.80 +0.89 (+0.84%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IPAR vs. CELH, COTY, ELF, LW, MED, NUS, POST, PBH, HLF, and USNAShould you be buying Interparfums stock or one of its competitors? The main competitors of Interparfums include Celsius (CELH), Coty (COTY), e.l.f. Beauty (ELF), Lamb Weston (LW), MEDIFAST (MED), Nu Skin Enterprises (NUS), Post (POST), Prestige Consumer Healthcare (PBH), Herbalife (HLF), and USANA Health Sciences (USNA). Interparfums vs. Its Competitors Celsius Coty e.l.f. Beauty Lamb Weston MEDIFAST Nu Skin Enterprises Post Prestige Consumer Healthcare Herbalife USANA Health Sciences Interparfums (NASDAQ:IPAR) and Celsius (NASDAQ:CELH) are related companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership. Is IPAR or CELH more profitable? Interparfums has a net margin of 11.03% compared to Celsius' net margin of 7.91%. Celsius' return on equity of 36.88% beat Interparfums' return on equity.Company Net Margins Return on Equity Return on Assets Interparfums11.03% 16.45% 11.14% Celsius 7.91%36.88%10.24% Which has higher valuation and earnings, IPAR or CELH? Interparfums has higher revenue and earnings than Celsius. Interparfums is trading at a lower price-to-earnings ratio than Celsius, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInterparfums$1.46B2.35$164.36M$4.9921.40Celsius$1.36B10.83$145.07M$0.37153.88 Which has more risk & volatility, IPAR or CELH? Interparfums has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Celsius has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Do analysts prefer IPAR or CELH? Interparfums presently has a consensus price target of $162.00, indicating a potential upside of 51.69%. Celsius has a consensus price target of $61.95, indicating a potential upside of 8.81%. Given Interparfums' stronger consensus rating and higher possible upside, research analysts clearly believe Interparfums is more favorable than Celsius.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Interparfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Celsius 1 Sell rating(s) 3 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 2.77 Does the media favor IPAR or CELH? In the previous week, Celsius had 13 more articles in the media than Interparfums. MarketBeat recorded 27 mentions for Celsius and 14 mentions for Interparfums. Interparfums' average media sentiment score of 1.16 beat Celsius' score of 0.91 indicating that Interparfums is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Interparfums 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celsius 13 Very Positive mention(s) 5 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of IPAR or CELH? 55.6% of Interparfums shares are held by institutional investors. Comparatively, 61.0% of Celsius shares are held by institutional investors. 43.7% of Interparfums shares are held by insiders. Comparatively, 2.2% of Celsius shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryInterparfums beats Celsius on 10 of the 16 factors compared between the two stocks. Get Interparfums News Delivered to You Automatically Sign up to receive the latest news and ratings for IPAR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPAR vs. The Competition Export to ExcelMetricInterparfumsCONSM PD IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$3.42B$2.30B$8.41B$10.26BDividend Yield2.95%4.21%3.00%4.60%P/E Ratio21.3517.0518.4326.44Price / Sales2.353.035.1388.47Price / Cash17.4516.6614.9729.91Price / Book3.631.695.096.27Net Income$164.36M$103.49M$254.99M$270.47M7 Day Performance-6.09%1.14%1.42%2.74%1 Month Performance-5.32%4.34%18.78%5.95%1 Year Performance-9.14%-12.86%51.56%25.97% Interparfums Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPARInterparfums4.4053 of 5 stars$106.80+0.8%$162.00+51.7%-9.2%$3.42B$1.46B21.35530Positive NewsCELHCelsius3.7145 of 5 stars$55.64-4.7%$61.42+10.4%+71.6%$15.06B$1.36B73.891,073COTYCoty4.8242 of 5 stars$4.32-1.3%$6.19+43.5%-55.2%$3.81B$5.89B19.8611,636ELFe.l.f. Beauty3.7533 of 5 stars$138.15+3.1%$129.94-5.9%+16.0%$7.95B$1.31B61.45300Insider TradeLWLamb Weston4.7519 of 5 stars$57.53-0.8%$65.30+13.5%-11.9%$8.08B$6.45B17.2610,100News CoveragePositive NewsMEDMEDIFAST3.731 of 5 stars$13.81+1.9%$16.50+19.5%-26.0%$148.93M$602.46M35.66870News CoveragePositive NewsNUSNu Skin Enterprises3.519 of 5 stars$11.53+0.3%$6.88-40.3%+57.5%$568.73M$1.73B9.503,100POSTPost4.4628 of 5 stars$106.34-1.8%$131.20+23.4%-9.0%$5.88B$7.92B16.1611,480Trending NewsShort Interest ↑PBHPrestige Consumer Healthcare4.5683 of 5 stars$65.68+1.0%$93.33+42.1%-14.6%$3.20B$1.14B14.20540Positive NewsHLFHerbalife4.2855 of 5 stars$9.85-0.1%$11.50+16.7%+28.8%$1.02B$4.99B4.678,600Positive NewsUSNAUSANA Health Sciences3.9916 of 5 stars$30.90-2.9%$36.00+16.5%-20.5%$581.41M$854.50M11.921,700Positive News Related Companies and Tools Related Companies CELH Competitors COTY Competitors ELF Competitors LW Competitors MED Competitors NUS Competitors POST Competitors PBH Competitors HLF Competitors USNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPAR) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interparfums, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interparfums With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
